Effects of Antimuscarinic Drugs on Overactive Bladder (OAB) Symptoms After Insertion of Ureteral Stents

Clalit Health Services

Status: Withdrawn

Conditions: Overactive Bladder

Study type: Observational

Funder types: Other

Identifiers

NCT01210859

URSTDETRUSITOL

Details and patient eligibility

About

The purpose of this study is to check whether antimuscarinics that usually broadly used in the treatment of overactive bladder symptoms are effective in the treatment of those symptoms after insertion of ureteral stents. In order to study the efficacy of the treatment of OAB symptoms in stented patients the investigator will use a suitable questionnary.

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• everyone who underwent ureteral stent insertion and started the treatment with detrusitol

Exclusion criteria

• adverse affects of detrusitol or unwillness of the patient to continue the treatment with detrusitol, cronic renal or hepatic failure

Trial design

0 participants in 1 patient group

Ureteral stents Detrusitol treatment Lyfestyle outcome

Description:

Ureteral stents Detrusitol treatment Lyfestyle outcome